Sartorius Aktiengesellschaft (OTCMKTS:SARTF – Get Free Report) released its earnings results on Monday. The company reported $1.11 earnings per share for the quarter, Zacks reports. Sartorius Aktiengesellschaft had a net margin of 2.50% and a return on equity of 7.69%. The business had revenue of $967.37 million during the quarter.
Sartorius Aktiengesellschaft Price Performance
Shares of SARTF remained flat at $205.97 during midday trading on Wednesday. The company has a 50-day simple moving average of $206.55 and a 200-day simple moving average of $205.79. Sartorius Aktiengesellschaft has a 1-year low of $175.93 and a 1-year high of $313.00. The company has a debt-to-equity ratio of 1.17, a quick ratio of 1.13 and a current ratio of 2.02.
Analyst Upgrades and Downgrades
Several research firms recently weighed in on SARTF. Wolfe Research raised shares of Sartorius Aktiengesellschaft to a “strong-buy” rating in a research note on Thursday, November 14th. Guggenheim raised shares of Sartorius Aktiengesellschaft to a “strong-buy” rating in a research note on Thursday, December 19th.
About Sartorius Aktiengesellschaft
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers.
Featured Articles
- Five stocks we like better than Sartorius Aktiengesellschaft
- What is an Earnings Surprise?
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
- What does consumer price index measure?
- Solid Biosciences Soars 32% on Trial Data: 189% Upside from Here?
- How to Profit From Growth Investing
- Up Nearly 1000%, Can AppLovin Keep Delivering for Investors?
Receive News & Ratings for Sartorius Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.